Rocket Lab Delays Neutron Rocket Debut to 2027 Amid Manufacturing Defect

Key points

• Rocket Lab moved the first Neutron launch to 2027 after identifying a defect in the forward propellant dome of the first-stage tank.
• Shares of Rocket Lab (RKLB) fell nearly 7% on October 15, closing at $55.25 after dropping as much as 16% intraday.
• The stock broke below the key $60 technical support level, signaling potential further downside for investors.
• Wall Street analysts generally maintained bullish ratings but lowered price targets, with KeyCorp cutting its target to $100 from $135.
• Rocket Lab’s existing Electron business and a $2.36 billion backlog provide stability, but profitability depends on Neutron's success.

Background

Rocket Lab’s Neutron rocket was originally announced in early 2021 as a key driver for entering the medium-lift market. Previous delays have already raised concerns about execution timelines. The company’s current profitability and cash-flow positivity are heavily tied to the successful launch of Neutron, making this delay a significant setback for its financial roadmap.

How outlets are covering it

MarketBeat and Seeking Alpha both highlight the negative market reaction and technical breakdown of RKLB stock, noting the drop below $60. However, they emphasize that most analysts remain bullish, with consensus targets still implying significant upside. Space.com focuses on the operational delay itself, confirming the shift to 2027. While some outlets like Weiss Ratings maintain a Sell rating, the broader analyst community, including TD Cowen and Cantor Fitzgerald, has reiterated Buy ratings despite lower price targets.

Why it matters

The delay impacts Rocket Lab’s path to profitability and its ability to compete in the lucrative medium-lift market. It tests investor confidence in the company’s execution capabilities and could influence future investment decisions in the space sector.

What to watch

Investors will watch for Rocket Lab to reclaim the $60 price level and for updates on the Neutron manufacturing process. The company must demonstrate that it can resolve the defect and launch successfully in 2027 to maintain its growth narrative.